review Open AccessTop 1% cited
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
The Journal of Infectious Diseases · 2014 · Vol. 211(1) · pp. 80–90
John Mair-Jenkins(Public Health England)María Saavedra-Campos(Public Health England)J. Kenneth Baillie(Roslin Institute)Paul Cleary(Public Health England)Fu-Meng Khaw(Public Health England)Wei Shen Lim(Nottingham University Hospitals NHS Trust)Sophia Makki(Public Health England)Kevin Rooney(University of the West of Scotland)Convalescent Plasma Study Group(University of Nottingham)Jonathan S. Nguyen‐Van‐Tam✉(University of Nottingham)Charles Beck(University of Nottingham)
Abstract
Convalescent plasma may reduce mortality and appears safe. This therapy should be studied within the context of a well-designed clinical trial or other formal evaluation, including for treatment of Middle East respiratory syndrome coronavirus CoV infection.
Respiratory viral infections researchPediatric health and respiratory diseasesSARS-CoV-2 and COVID-19 ResearchConvalescent plasmaMedicineImmunologyAntibodyMeta-analysisEtiologyRespiratory systemVirologyCoronavirus disease 2019 (COVID-19)Internal medicine
MeSH terms
HumansImmunoglobulinsInfluenza, HumanPlasmaProspective StudiesRespiratory Tract InfectionsRiskSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirus
Funding
- World Health Organization
- Public Health Agency
- Public Health England
- Universitetet i Bergen
- Haukeland Universitetssjukehus
- Folkhälsomyndigheten
Citations
1,038
FWCI
19.52
field-weighted impact
References
53
Percentile
100%
vs. same field & year
Citations per year
Cited by
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Critical Care Medicine · 2020 · 1,612 citations
SARS and MERS: recent insights into emerging coronaviruses
Nature Reviews Microbiology · 2016 · 3,707 citations
Convalescent plasma as a potential therapy for COVID-19
The Lancet Infectious Diseases · 2020 · 1,086 citations
Coronaviruses — drug discovery and therapeutic options
Nature Reviews Drug Discovery · 2016 · 1,783 citations
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Intensive Care Medicine · 2020 · 2,182 citations
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Clinica Chimica Acta · 2020 · 1,046 citations
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Nature Structural & Molecular Biology · 2020 · 546 citations
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
Journal of Clinical Medicine · 2020 · 587 citations
References
Systematic reviews: CRD's guidance for undertaking reviews in health care
The Lancet Infectious Diseases · 2010 · 3,272 citations
SARS: Systematic Review of Treatment Effects
PLoS Medicine · 2006 · 1,268 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Journal of Clinical Epidemiology · 2009 · 19,782 citations
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Medical Entomology and Zoology · 2014 · 17,868 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine · 2009 · 63,014 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.